• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

1.380 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ikena Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
On Thursday, there are stocks with unusual volume. Let's take a look.
July 17, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 15, 2025
Via Benzinga
Tuesday's after hours session: top gainers and losers
July 15, 2025
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 23, 2024
Via Benzinga
The Analyst Landscape: 4 Takes On Ikena Oncology
March 19, 2024
Via Benzinga
Ikena Oncology: Q4 Earnings Insights
March 12, 2024
Via Benzinga
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024
August 09, 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It 'Disappointing'
May 29, 2024
Ikena Oncology halts its IK-930 program after reviewing clinical data and resources, focusing on the novel MEK-RAF molecular glue, IK-595. 
Via Benzinga
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 29, 2024
Via Benzinga
Ikena Oncology: Q3 Earnings Insights
November 09, 2023
Via Benzinga
Analyst Ratings for Ikena Oncology
May 16, 2023
Via Benzinga
This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
May 29, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 29, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 29, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers traders are going to want to watch on Wednesday morning! 
Via InvestorPlace
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024
May 13, 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via Benzinga
Ikena Oncology Refocuses on Key Programs: Analysts Maintain Outperform Ratings Amid Strategic Organizational Changes
January 19, 2024
Ikena Oncology optimizes resources for targeted oncology programs IK-930 & IK-595. Clinical updates expected H2 2024. Workforce reduced by 35%. Financially secure with $175M cash. Strategic focus on... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 24, 2023
Via Benzinga
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 24, 2023
Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray into the Middle Ea 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via Benzinga
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results
November 09, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500... 
Via Benzinga
Topics Stocks
Why Is Cancer Firm Ikena Oncology Stock Trading Lower Today?
November 09, 2023
Ikena Oncology Inc (NASDAQ: IKNA) shared initial data from twenty-six patients treated in the ongoing dose escalation portion of the  
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via Benzinga
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
November 09, 2023
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53.... 
Via Benzinga
Topics Stocks
Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform
September 22, 2023
Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 08, 2023
We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday! 
Via InvestorPlace
Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move
August 07, 2023
Ikena Oncology Inc (NASDAQ: IKNA) acquired Pionyr Immunotherapeutics Inc, a privately-held biotechnology company, in  
Via Benzinga
< Previous 1 2 3 4 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap